Reports showed that the vitamin D analog 1α,25(OH)2D3 may be effective for the treatment of oral squamous cell carcinoma by inhibiting the activity of the NF-κB [24]. The gene discussed is NFKB1; the disease is oral cavity squamous cell carcinoma.